Ultra Sun Corp (CBDS) 10.7000 $CBDS
Health & Wellness Industry Gets Excited by Recent Federal Medical Marijuana Legalization Efforts - Company Initiates Cannabis Drug Development Plan
PR Newswire - Fri Aug 01, 8:05AM CDT
Pharmaceutical, Wellness and Cannabis companies stand out in health sector with continual growth and significant acquisitions of resources: Crown Baus Capital Corp. (OTC: CBCA), Cannabis Sativa, Inc. (OTC: CBDS), GW Pharmaceuticals plc (NASDAQ: GWPH), Avalanche Biotechnologies Inc. (NASDAQ: AAVL) and Healthequity Inc. (NASDAQ: HQY)
CannLabs Continues to Make Tremendous Strides
ACCESSWIRE - Thu Jul 17, 9:04AM CDT
WHITEFISH, MT / July 17, 2014 / CannLabs, Inc. (OTCQB: CANL), a solutions provider with intellectual property, proprietary cloud-based analytics, and scientific methods to serve the cannabis industry, recently announced a series of moves that help to solidify its position within the rapidly growing U.S. cannabis industry, which some analysts believe will reach $2.57 billion in size in 2014.*
Cannabis Sativa, Inc., Analyst Report; The Plan is in Place, Time to Execute the Deal by BrokerBank Securities, Inc.
PR Newswire - Mon Jul 14, 1:00PM CDT
Cannabis Sativa, Inc. (OTCQB: CBDS) is a development stage company that hopes to capitalize on the legalization of marijuana. The company started business in April of 2013 through a reverse takeover. It acquired an exchange listed shell company and sold off the shell's assets as a way of side stepping the heavily regulated IPO process. CBDS's products include herbal skin care, formulas, edibles, topicals, delivery systems, and recipes related to cannabis. The feature products are cannabis lozenges, and its "Skin Garden" skin care line. The lozenges use a strain of cannabis called NZT, and they begin to act in 5-10 minutes. This is in contrast to other edibles that take up to an hour to act. CBDS has patents pending on powerful strains of cannabis to be used in products. The company has a great team in place albeit small, and the potential addressable market is large. There are many obstacles left for the company though before becoming a viable business. CBDS has patents pending, further legislation around marijuana legalization is up in the air, competition is stiff, and the right partners need to be found.
Cannabis Stocks Move Higher as Washington State Pot Sales Begin
ACCESSWIRE - Mon Jul 14, 8:30AM CDT
WHITEFISH, MT / July 14, 2014 / The Marijuana Index(TM) moved higher last week in the aggregate, despite a 13% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) shares and a roughly 1.5% drop in Medbox Inc. (OTC: MDBX) shares, which comprise about half of the weighted index.
OTC Stocks Trading News: Fannie Mae, Immune Pharmaceuticals, Inc. Cannabis Sativa, Inc. United Cannabis Corp, Cynk Technology Corp.
PR Newswire Europe - Thu Jul 10, 7:01AM CDT
LONDON, July 10, 2014 /PRNewswire/ --
Cannabis Sativa & Easton Pharmaceuticals Led Cannabis Stocks Higher Last Week
ACCESSWIRE - Tue Jul 08, 8:07AM CDT
Whitefish, MT / July 8, 2014 / The Marijuana Index(tm) was mixed last week, as index heavyweights GW Pharmaceuticals plc (NASDAQ: GWPH) and Medbox Inc. (OTC: MDBX) gave up some of their earlier gains towards the end of the week.
Medican Director Assumes New Leadership Position as CEO of Cannabis Sativa Inc.
Business Wire - Mon Jul 07, 7:00AM CDT
Medican Enterprises, Inc. (OTCBB:MDCN) a bio-pharmaceutical company focused on developing, and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market is pleased to announce its director, Gary Johnson, was recently appointed CEO of Cannabis Sativa Inc. (OTCQB:CBDS).
Cannabis Sativa, Inc. Completes the Acquisition of Kush and Names Former New Mexico Governor Gary Johnson as President and CEO, and Steve Kubby as Chairman
GlobeNewswire - Tue Jul 01, 2:30AM CDT
Cannabis Sativa, Inc. (OTCQB:CBDS) announced today that on June 30, 2014, it consummated the acquisition of Kush, a Nevada corporation ("Kush"
, and its consolidated subsidiary, following which Kush became a wholly owned subsidiary of the Company (the "Merger" .
Pot Stocks: Not As Green As They Seem
at The Street - Tue Feb 11, 11:17AM CST
There's a big spotlight on pot stocks following the recent push to legalize marijuana, but many are not as green as they seem.
The Deal: Pot Stocks Are Smokin'
at The Street - Wed Jan 08, 4:17PM CST
Shares of Cannabis Sativa, MedBox and GreenGro soar as more states move to loosen marijuana laws.
Cannabis Sativa, Inc. Signs Purchase Agreement for Patent Pending Hybrid Marijuana Strain CTA and Option to Acquire KUSH for $1 Million
GlobeNewswire - Thu Jan 02, 6:31AM CST
Cannabis Sativa, Inc. (OTCBB:CBDS) announced today that on January 1, 2014, it has signed an agreement to purchase a patent pending for a new, super potent medicinal cannabis strain. The agreement also provides CBDS with an option to purchase KUSH, Inc., the owner of the patent pending, for an additional $1 million. The strain, called CTA, has been under review by the US Patent Office since April 30, 2010, and is expected to be issued a patent soon.
Health & Wellness Industry Gets Excited by Recent Federal Medical Marijuana Legalization Efforts - Company Initiates Cannabis Drug Development Plan
PR Newswire - Fri Aug 01, 8:05AM CDT
Pharmaceutical, Wellness and Cannabis companies stand out in health sector with continual growth and significant acquisitions of resources: Crown Baus Capital Corp. (OTC: CBCA), Cannabis Sativa, Inc. (OTC: CBDS), GW Pharmaceuticals plc (NASDAQ: GWPH), Avalanche Biotechnologies Inc. (NASDAQ: AAVL) and Healthequity Inc. (NASDAQ: HQY)
CannLabs Continues to Make Tremendous Strides
ACCESSWIRE - Thu Jul 17, 9:04AM CDT
WHITEFISH, MT / July 17, 2014 / CannLabs, Inc. (OTCQB: CANL), a solutions provider with intellectual property, proprietary cloud-based analytics, and scientific methods to serve the cannabis industry, recently announced a series of moves that help to solidify its position within the rapidly growing U.S. cannabis industry, which some analysts believe will reach $2.57 billion in size in 2014.*
Cannabis Sativa, Inc., Analyst Report; The Plan is in Place, Time to Execute the Deal by BrokerBank Securities, Inc.
PR Newswire - Mon Jul 14, 1:00PM CDT
Cannabis Sativa, Inc. (OTCQB: CBDS) is a development stage company that hopes to capitalize on the legalization of marijuana. The company started business in April of 2013 through a reverse takeover. It acquired an exchange listed shell company and sold off the shell's assets as a way of side stepping the heavily regulated IPO process. CBDS's products include herbal skin care, formulas, edibles, topicals, delivery systems, and recipes related to cannabis. The feature products are cannabis lozenges, and its "Skin Garden" skin care line. The lozenges use a strain of cannabis called NZT, and they begin to act in 5-10 minutes. This is in contrast to other edibles that take up to an hour to act. CBDS has patents pending on powerful strains of cannabis to be used in products. The company has a great team in place albeit small, and the potential addressable market is large. There are many obstacles left for the company though before becoming a viable business. CBDS has patents pending, further legislation around marijuana legalization is up in the air, competition is stiff, and the right partners need to be found.
Cannabis Stocks Move Higher as Washington State Pot Sales Begin
ACCESSWIRE - Mon Jul 14, 8:30AM CDT
WHITEFISH, MT / July 14, 2014 / The Marijuana Index(TM) moved higher last week in the aggregate, despite a 13% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) shares and a roughly 1.5% drop in Medbox Inc. (OTC: MDBX) shares, which comprise about half of the weighted index.
OTC Stocks Trading News: Fannie Mae, Immune Pharmaceuticals, Inc. Cannabis Sativa, Inc. United Cannabis Corp, Cynk Technology Corp.
PR Newswire Europe - Thu Jul 10, 7:01AM CDT
LONDON, July 10, 2014 /PRNewswire/ --
Cannabis Sativa & Easton Pharmaceuticals Led Cannabis Stocks Higher Last Week
ACCESSWIRE - Tue Jul 08, 8:07AM CDT
Whitefish, MT / July 8, 2014 / The Marijuana Index(tm) was mixed last week, as index heavyweights GW Pharmaceuticals plc (NASDAQ: GWPH) and Medbox Inc. (OTC: MDBX) gave up some of their earlier gains towards the end of the week.
Medican Director Assumes New Leadership Position as CEO of Cannabis Sativa Inc.
Business Wire - Mon Jul 07, 7:00AM CDT
Medican Enterprises, Inc. (OTCBB:MDCN) a bio-pharmaceutical company focused on developing, and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market is pleased to announce its director, Gary Johnson, was recently appointed CEO of Cannabis Sativa Inc. (OTCQB:CBDS).
Cannabis Sativa, Inc. Completes the Acquisition of Kush and Names Former New Mexico Governor Gary Johnson as President and CEO, and Steve Kubby as Chairman
GlobeNewswire - Tue Jul 01, 2:30AM CDT
Cannabis Sativa, Inc. (OTCQB:CBDS) announced today that on June 30, 2014, it consummated the acquisition of Kush, a Nevada corporation ("Kush"
, and its consolidated subsidiary, following which Kush became a wholly owned subsidiary of the Company (the "Merger" . Pot Stocks: Not As Green As They Seem
at The Street - Tue Feb 11, 11:17AM CST
There's a big spotlight on pot stocks following the recent push to legalize marijuana, but many are not as green as they seem.
The Deal: Pot Stocks Are Smokin'
at The Street - Wed Jan 08, 4:17PM CST
Shares of Cannabis Sativa, MedBox and GreenGro soar as more states move to loosen marijuana laws.
Cannabis Sativa, Inc. Signs Purchase Agreement for Patent Pending Hybrid Marijuana Strain CTA and Option to Acquire KUSH for $1 Million
GlobeNewswire - Thu Jan 02, 6:31AM CST
Cannabis Sativa, Inc. (OTCBB:CBDS) announced today that on January 1, 2014, it has signed an agreement to purchase a patent pending for a new, super potent medicinal cannabis strain. The agreement also provides CBDS with an option to purchase KUSH, Inc., the owner of the patent pending, for an additional $1 million. The strain, called CTA, has been under review by the US Patent Office since April 30, 2010, and is expected to be issued a patent soon.
